Reduced Brain Cannabinoid Receptor Availability in Schizophrenia

Biological Psychiatry - Netherlands
doi 10.1016/j.biopsych.2015.08.021
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

In Vivo Determination of Muscarinic Acetylcholine Receptor Availability in Schizophrenia

American Journal of Psychiatry
PsychiatryMental Health
2003English

Reduced Brain-Derived Neurotrophic Factor in Prefrontal Cortex of Patients With Schizophrenia

Molecular Psychiatry
PsychiatryMolecular NeuroscienceMental HealthMolecular BiologyCellular
2003English

Circadian Variation of Metabotropic Glutamate Receptor 5 Availability in the Rat Brain

Journal of Sleep Research
MedicineBehavioral NeuroscienceCognitive Neuroscience
2016English

Molecular Interactions of Cannabinoid Receptor Interacting Protein 1 a and B With Cannabinoid Receptor 1

Biophysical Journal
Biophysics
2017English

Reduced Amplitude of Low-Frequency Brain Oscillations in the Psychosis Risk Syndrome and Early Illness Schizophrenia

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2016English

Cannabinoid Receptor CB2 Modulates Axon Guidance

PLoS ONE
Multidisciplinary
2013English

Cannabinoid-1 Receptor Antagonists in Type-2 Diabetes

Best Practice and Research in Clinical Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2007English

3′-Functionalized Adamantyl Cannabinoid Receptor Probes

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2015English

Obesity Is Associated With Decreased -Opioid but Unaltered Dopamine D2 Receptor Availability in the Brain

Journal of Neuroscience
Neuroscience
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy